Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Lemaitre Vascular ( (LMAT) ) just unveiled an update.
On February 7, 2025, LeMaitre Vascular, Inc. announced the appointment of Dorian LeBlanc as Chief Financial Officer, effective March 10, 2025. Mr. LeBlanc brings extensive experience from his previous roles at LumiraDx Limited and Alere Inc., enhancing LeMaitre’s financial leadership. His compensation package includes a base salary, performance bonus, and equity awards, with severance terms outlined in case of termination without cause, signaling a strategic reinforcement of the company’s financial management team.
More about Lemaitre Vascular
LeMaitre Vascular, Inc. operates in the medical device industry, focusing on developing and manufacturing innovative products for the treatment of peripheral vascular disease.
YTD Price Performance: 5.30%
Average Trading Volume: 162,664
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $2.17B
For detailed information about LMAT stock, go to TipRanks’ Stock Analysis page.
